skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

11 Total results for product and free and sample content found

Meddevicetracker

Discover the top medtech stories from the last week below

By Chris Farrell 25 Sep 2017

Meddevicetracker weekly round up  

Topic Medtech weekly roundup

Medtech Insight

View Of The IVD Horizon: How Roche Diagnostics Sees The Sector Evolving

By Tina Tan 18 Apr 2017

While the in vitro diagnostics landscape has seen players come and go, Roche Diagnostics has remained at the top. But the Swiss giant, like all its other smaller rivals, is facing a new reality, with increasing pressures to prove medical value, and a more stringent regulatory environment. Medtech Insight spoke to Roche Diagnostics' Jean-Claude Gottraux, head of centralized and point of care solutions, and Jean-Jacques Palombo, lifecycle leader for the company's cardiac, women's health and personalized health care solutions immunoassay portfolio, to gain their perspectives on how the sector has evolved and will continue to evolve. They also spoke about the company's strategy to address these changes and challenges.

Pink Sheet

Biogen CMO Notes iPhone's Potential For Early Detection of Alzheimer's

By Sten Stovall 05 Apr 2017

Biogen's chief medical officer says iPhone technology should in future be used for early warning diagnosis of Alzheimer's Disease.

Topic Alzheimers

Pink Sheet

A Look At Payers' Early Game Plans For Driving Biosimilar Use

By Emily Hayes 05 Apr 2017

Interviews with US payers suggest that at first they are more likely to focus on promoting biosimilars in treatment-naïve patients, as opposed to switching those on branded drugs, according to a new Datamonitor report.

Topic Biosimilars

Pink Sheet

User Fee Bill Could Become Ensnared In US Abortion Politics

By Derrick Gingery 31 Mar 2017

Amendment defunding Planned Parenthood is one ACA repeal refugee that could hitch a ride with user fee bill, which would be 'problematic,' to say the least, for Democrats.

Pink Sheet

US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

By Bowman Cox 17 Jan 2017

Congressional oversight agency urges FDA to make better use of foreign offices with more effective performance measures and staffing goals; GAO notes agency’s progress towards risk-based inspections – and its plan to revisit every site at least once every five years.

Scrip

From Solanezumab To Solithromycin: What To Watch For In Q4

11 Oct 2016

Lilly’s solanezumab, Roche/Genentech’s Ocrevus and Cempra’s solithromycin are among the key therapies scheduled for major data read-outs or approval decisions in Q4 2016.

Topic Clinical trial optimization

Medtech Insight

Brexit where do notified body, authorized representative offices need to be?

By Amanda Maxwell 10 Oct 2016

Medtech regulatory service providers cannot afford to "wait and see" on the final outcome of Brexit. Questions such as the appropriate base of operations to serve device companies looking to

Topic Brexit

Scrip

Merck's Keytruda Chemo-Combo Data Has Big Implications For Future Of Immuno-Oncology

By Jessica Merril 10 Oct 2016

Merck’s strong Phase II data testing Keytruda with chemotherapy

Topic immuno-oncology

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: